Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Holding ALGS?
Track your performance easily

Aligos Therapeutics (ALGS) Balance Sheet

106 Followers

Aligos Therapeutics Balance Sheet

Aligos Therapeutics's total assets for Q2 2024 were $108.81M, a decrease of -14.93% from the previous quarter. ALGS total liabilities were $41.58M for the fiscal quarter, a -38.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 151.53M$ 146.69M$ 235.41M$ 265.30M$ 146.52M
Total Liabilities
$ 59.45M$ 42.79M$ 50.64M$ 45.26M$ 211.41M
Total Equity Gross Minority
$ 92.08M$ 103.92M$ 184.70M$ 220.04M$ -64.89M
Total Capitalization
$ 99.98M$ 113.33M$ 184.70M$ 220.04M$ -64.89M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 13.01M$ 14.33M
Currency in USD

Aligos Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis